Novel Drug Delivery Technologies
IRISYS develops formulations for new chemical entities and ANDA/generic products. We also have experience developing formulations with 505(b)(2) product candidates, which can rely in part on data from existing reference drugs. Our formulations can support the expansion of our clients’ intellectual property portfolios.
Controlled release formulations
- Solid oral
- Liquid oral